PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

An easy breath test could mean new hope in the early detection of pancreatic cancer, and medical experts say it could be the ...

Pancreatic cancer is the seventh most common type of cancer in Europe but is the fourth leading cause of cancer-related deaths, behind lung, colorectal, and breast cancers. By 2030, it is widely ...

A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...

Pancreatic cancer is cancer that starts in the pancreas. The pancreas makes enzymes and hormones vital for promoting digestion and regulating blood sugar. Specific biomarkers, called tumor markers, ...

The High Risk Pancreatic Cancer Clinic at Huntsman Cancer Institute offers many services to people with an increased risk of pancreatic cancer. We do the following: Provide information about the ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

Pancreatic cancer is inoperable when the cancer cannot be completely removed with surgery. Some treatment options include chemotherapy, radiation, and targeted therapy. Pancreatic cancer is inoperable ...

A new mRNA vaccine could prevent pancreatic cancer from returning — potentially for the long haul. In a small clinical trial, some patients who received the vaccine remained cancer-free for more than ...